Full text is available at the source.
Recent advances in antituberculous drug development and novel drug targets
New developments and targets for tuberculosis medicines
AI simplified
Abstract
Advances in understanding Mycobacterium tuberculosis may aid in the development of new anti-tuberculous drugs.
- Critical information on the entire genome of Mycobacterium tuberculosis has been elucidated.
- Knowledge of various mycobacterial virulence genes may enhance the identification of new drug targets.
- Potential pharmacological targets for future anti-tuberculous drug development include specific genes related to MTB.
- Promising new anti-tuberculous agents under development include nitroimidazoles, diarylquinolines, and oxazolidinones.
AI simplified